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Abstract
Background: Socioeconomic status (SES) predicts coronary heart disease independently of the traditional risk
factors included in the Framingham risk score. However, it is unknown whether changes in Framingham risk score
variables over time explain the association between SES and coronary heart disease. We examined this question
given its relevance to risk assessment in clinical decision making.
Methods: The Atherosclerosis Risk in Communities study data (initiated in 1987 with 10-years follow-up of 15,495
adults aged 45-64 years in four Southern and Mid-Western communities) were used. SES was assessed at baseline,
dichotomized as low SES (defined as low education and/or low income) or not. The time dependent variables -
smoking, total and high density lipoprotein cholesterol, systolic blood pressure and use of blood pressure lowering
medication - were assessed every three years. Ten-year incidence of coronary heart disease was based on EKG and
cardiac enzyme criteria, or adjudicated death certificate data. Cox survival analyses examined the contribution of
SES to heart disease risk independent of baseline Framingham risk score, without and with further adjustment for
the time dependent variables.
Results: Adjusting for baseline Framingham risk score, low SES was associated with an increased coronary heart
disease risk (hazard ratio [HR] = 1.53; 95% Confidence Interval [CI], 1.27 to1.85). After further adjustment for the
time dependent variables, the SES effect remained significant (HR = 1.44; 95% CI, 1.19 to1.74).
Conclusion: Using Framingham Risk Score alone under estimated the coronary heart disease risk in low SES
persons. This bias was not eliminated by subsequent changes in Framingham risk score variables.
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Background
Low socio-economic status (SES) predicts coronary
heart disease independent of traditional risk factors
included in the Framingham risk score [1-7], particularly
in high income countries [8,9]. We previously reported
that adding a measure of SES to CHD risk assessment
based on Framingham risk scoring also improves model
calibration (i.e. corrects under estimation of risk) for
low SES persons [1,10]. This finding suggests that con-
sideration of SES in the context of clinical decision mak-
ing for cholesterol treatment may help address SES
disparities in coronary heart disease [11]. Specifically,
correction of risk underestimation for low SES persons
may allow for better alignment between risk and treat-
ment (e.g. more aggressive cholesterol lowering treat-
ment) for low SES persons, potentially reducing
disparities. Importantly, this risk-based approach is
intended to augment, rather than supplant, broader
approaches to disparities CHD risk [12].
A lingering concern with the above approach is the
possibility that the independent association of SES with
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Framingham risk score variables over time. For example,
low SES persons are less likely to stop smoking [13],
and often have less access to care, including less use of
medications shown to decrease coronary heart disease
risk [14]; thus, SES may act through effects on Framing-
ham risk score variables over time. If such a pathway
explained the independent baseline association of SES
with subsequent coronary heart disease, it would not be
necessary to adjust risk stratification and treatment
goals for differences in SES. Periodic updating of Fra-
mingham Risk Scoring would be sufficient to account
for the effect of SES on CHD risk.
Most prior studies evaluating putative coronary heart
disease risk factors (whether behavioral or biomedical)
have focused on whether the putative risk factor mea-
sured at baseline exerts an influence on subsequent cor-
onary heart disease independent of baseline risk factors
included in the Framingham risk score. A few studies
have examined the impact of changes in risk factors on
SES-associated cardiovascular risk [15,16]. However,
prior studies have not specifically examined whether
changes in Framingham risk factors affect the relation-
ship between SES and CHD incidence. We examined
data from the Atherosclerosis Risk in Communities
(ARIC) study to assess the impact of changes over time
in Framingham risk score variables on the relationship
between baseline SES and subsequent coronary heart
disease.
Methods
Sample
This study is based on publicly available ARIC data. It
conformed to the Helsinki Declaration and local regula-
tions. It was approved by the University of Rochester
and the University of California, Davis Institutional
Review Boards. All patients were consented for partici-
pation in the original ARIC study from which this sec-
ondary data analysis is performed.
ARIC was implemented in four US communities and
designed to examine the natural history of atherosclero-
sis [17]. Field centers randomly selected and recruited a
sample of approximately 4,000 individuals aged 45-64
years in Forsyth County, North Carolina (75% urban),
Jackson, Mississippi (100% urban), Minneapolis suburbs,
Minnesota (100% urban), and Washington county,
Maryland (57% urban). In 1987-9, participants were
examined, yielding medical and socio-demographic data.
Follow-up is ongoing, with examinations every three
years. Roughly 75% of eligible respondents participated
in the baseline interview and 80% of these participated
in the baseline examination [18].
T h e r ew e r e1 5 , 7 3 2p a r t i c i p a n t si nt h es t u d y .W e
excluded the 17% of participants reporting coronary
heart disease or equivalents (stroke, peripheral vascular
disease, or diabetes) at baseline because current guide-
lines recommend aggressive treatment for this group
(and they are not scored in the Framingham risk scoring
system). We also excluded less than 1% of subjects with
missing Framingham risk score data elements resulting
in a study sample of 12,684. Because of missing SES
information (primarily income) 12,139 persons were
included in the analyses, with 3315 (27%) in the low
SES category (defined below). In terms of missing fol-
low-up data, 5% missed one eligible follow-up examina-
tion, and 1.5% missed two. Missing follow-up data were
more common among low SES persons (12%) than
among high SES persons (4%).
Details regarding data collection and analytic methods
for ARIC are published elsewhere [19]. ARIC subjects
were asked to fast for 12 hours before their examination
visits. For lipid testing, samples were sent to the Central
Lipid Laboratory (Houston, Texas). Total cholesterol
was determined by enzymatic methods. High density
lipoprotein (HDL) cholesterol was measured after dex-
tran-magnesium precipitation [20]. Systolic blood pres-
sure was measured three times, five minutes apart using
a random zero sphygmomanometer while the partici-
pant was seated. The average of the measures was used
for the analysis. Information on smoking status (smok-
ing or not) and anti-hypertensive medication use (or
not) were obtained by self-report.
Data regarding coronary heart disease events and risk
factors were collected through annual telephone inter-
views, follow-up examinations every three years, surveys
of hospital discharge data, and death certificates from
state vital statistics offices [17].
SES
We used a dichotomous measure of SES (low SES or
high SES) using income and education; the measure had
been previously validated [1]. We defined persons as
low SES if they had < 12 years of schooling and/or had
household incomes < $12,000 (corresponding to 50%
above the US federal poverty level for income an aver-
age U.S. household in 1987) [21]. This simplification
of SES was adopted to facilitate its easy incorporation
into clinical risk stratification and treatment goals
[1-4,11,22,23].
Framingham Risk Scoring
We used Framingham risk scoring to derive the 10-year
risk for a coronary heart disease event or death for men
and women as proposed in the National Cholesterol
Education Program. Framingham risk scoring uses parti-
cipant age (10 categories), gender (male/female), total
cholesterol (five categories), HDL cholesterol (four cate-
gories), smoking status (yes/no), systolic blood pressure
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no) among persons with two or more major coronary
heart disease risk factors (smoking, hypertension, low
HDL, family history of premature coronary heart dis-
ease, and age) to assign points. The precise categories
for each variable and the point scoring system that we
used have been published elsewhere [24].
Coronary Heart Disease Events
We assessed the timing (to the day) of the first of any
coronary heart disease event up to 10 years following
enrollment. Subjects not observed to develop coronary
heart disease within 10 years were considered censored
(or who died of other causes prior to 10 years). We fol-
lowed the Atherosclerosis Risk in Communities study
criteria for the diagnosis of incident coronary heart dis-
ease; diagnosis was based on EKG and cardiac enzyme
criteria, or death certificate data and arbitrated by an
Atherosclerosis Risk in Communities physician panel
[25].
Time Dependent Variables
In addition to baseline measurement, data on blood
pressure, total and HDL cholesterol, smoking status, and
use of anti-hypertensive medication were collected dur-
ing the course of three follow-up examinations con-
ducted every three years.
Analyses
Analyses used STATA (version 11.1, StataCorp, College
Station, TX). We used Cox proportional hazards analyses
to assess the influence of baseline and time-varying cov-
ariates on the incidence of the initial CHD event during
a 10-year follow-up period. Four models were developed.
Model 1 examined the effect of SES alone and Model 2
examined the effect of the Framingham risk score alone.
Model 3 included both the baseline Framingham risk
score and SES. Model 4 added the time dependent vari-
ables reflecting the values at each follow-up visit: systolic
blood pressure, total and HDL cholesterol, smoking sta-
tus, and use of anti-hypertensive medication. These time-
dependent variables were included as change scores from
their respective baseline values.
To better reflect the influence of the Framingham risk
score on CHD incidence, the Framingham risk score (on
a probability scale) was modeled as its complementary
log-log transform (log[-log[1-Framingham risk score]]).
Effect measure modification of the SES-CHD association
was examined by gender, race (Black vs. White),
Framingham risk score and by diastolic blood pressure.
None of these additional variables made statistically
significant contributions and the results of these analyses
are not reported. The proportional hazards assumption of
the Cox models were assessed graphically and statistically.
No evidence for a substantive departure from proportion-
ality was observed for any of our covariates, although a
slight departure was observed with the transformed base-
line FRS score toward the end of the 10-year follow-up
period. Alternative parameterizations of FRS eliminated
the departure from nonproportionality but at the expense
of substantially poorer overall model fit and with only
slight differences in the coefficients for the other terms in
the model. In light of this, we retained the original speci-
fication of the baseline FRS score (that used the comple-
mentary log-log transformation).
Results
Table 1 shows the characteristics of the study sample by
SES at baseline and the three follow-up examinations.
Table 1 Baseline and follow-up characteristics of study
sample
Higher SES Lower SES
Mean (SD) N Mean (SD) N
Baseline
Age (years) 53.3 (5.6) 8824 55.2 (5.7) 3315
Male 44.9% 8824 40.7% 3315
Framingham risk score 5.8 (6.0) 8824 7.0 (6.6) 3315
Total cholesterol (mg/dL) 212.3 (40.1) 8824 216.4 (43.7) 3315
HDL cholesterol mg/dL) 52.7 (17.0) 8824 52.9 (17.2) 3315
Systolic blood pressure (mm Hg) 118.0 (16.9) 8824 125.2 (20.0) 3315
Current smoker 22.9% 8824 34.9% 3315
Anti-hypertensive medication 17.8% 8785 28.8% 3300
3-year follow-up
Total cholesterol
(mg/dL)
207.8 (37.8) 8451 211.0 (40.3) 2928
HDL cholesterol
(mg/dL)
50.5 (16.8) 8424 50.3 (16.8) 2922
Systolic blood pressure (mm Hg) 119.2 (17.5) 8483 125.1 (20.2) 2945
Current smoker 19.8% 8467 29.6% 2932
Anti-hypertensive medication 20.4% 8457 31.9% 2928
6-year follow-up
Total cholesterol (mg/dL) 206.6 (36.4) 7844 208.8 (39.4) 2500
HDL cholesterol (mg/dL) 53.1 (18.3) 7843 52.1 (17.8) 2500
Systolic blood pressure (mm Hg) 122.2 (17.8) 7869 128.7 (20.5) 2515
Current smoker 15.9% 7848 23.5% 2494
Anti-hypertensive medication 25.6% 7834 37.4% 2498
9-year follow-up
Total cholesterol (mg/dL) 200.7 (35.9) 6974 202.1 (38.8) 1990
HDL cholesterol (mg/dL) 50.6 (16.6) 6974 49.4 (16.1) 1990
Systolic blood pressure (mm Hg) 125.3 (18.1) 6994 130.6 (19.5) 2001
Current smoker 13.0% 6969 19.5% 1991
Anti-hy2ertensive medication 30.5% 6965 42.3% 1988
Notes: SES = socio-economic status; SD = standard deviation; HDL = high
density lipoprotein.
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older, and had higher baseline Framingham risk scores,
reflecting their higher blood pressures and cholesterols,
greater likelihood to smoke and to be on anti-hyperten-
sive medication. There were 456 coronary heart disease
events during follow-up; the 10-year CHD incidence was
3.1% in high SES persons and 5.2% in low SES persons.
The higher coronary heart disease risk among low SES
persons persisted throughout follow-up and changes in
risk favored high SES persons throughout.
Table 2 summarizes the results of the Cox propor-
tional hazards models. In the model including baseline
Framingham risk score and SES (Model 3), low SES was
associated with an increased independent risk for coron-
ary heart disease; the adjusted effects of both were smal-
ler than when SES (Model 1) or Framingham risk score
(Model 2) were included alone. When the time depen-
dent risk factors were added to the model (Model 4),
the risk associated with SES remained significant.
Discussion
This is the first study to examine whether changes in
risk factors over time included in the Framingham risk
score could account for the effects of a putative social
risk factor for coronary heart disease. Specifically, we
assessed the hypothesis that the association of SES with
coronary heart disease adjusted for baseline measures of
traditional CHD risk factors is explained by changes in
those risk factors over time. We found that accounting
for these changes explained little of the risk associated
with SES.
No studies to our knowledge have examined the effect
of changes in FRS on the risk associated with SES on
CHD incidence. However, our findings are broadly con-
sistent with other studies examining cardiovascular dis-
ease. Stringhini et al examined the impact of baseline
health behaviors (rather than factors included in Fra-
mingham risk scoring) and their changes over time on
the association of SES with cardiovascular mortality in
British civil servants [16]. They found that baseline
health behaviors explained 29% of the effect of SES on
subsequent cardiovascular mortality. Notably, however,
subsequent health behavior changes over time accounted
for only 16% of the SES effect on cardio-vascular mor-
tality. Yan et al examined the effect of baseline systolic
blood pressure, smoking, waist circumference, physical
activity, and total cholesterol on coronary artery calcium
(CAC), a marker of subclinical atherosclerosis. Consis-
tent with our findings, baseline adjustment had an
appreciable effect on the risk associated with SES, but
adjustment for changes over 15 years had little effect
[15].
Our findings reinforce the current United Kingdom
recommendations of considering an individual’sS E Si n
assessing cardiovascular risk [22,26]. Specifically, our
findings show that changes in Framingham risk factors
explain little of the social risk for CHD. Thus, ignoring
SES in risk stratification and treatment goals may result
in undertreatment of low SES persons who are at higher
risk for cornary heart disease than their Framingham
risk score suggests. SES does not appear to be simply a
proxy for poor access and adherence (though those fac-
tors are likely also important).
Our study was not designed to address pathways
beyond the risk factors included in the Framingham risk
score that may explain the higher coronary heart disease
Table 2 Predictors of 10-year coronary heart disease without and with adjustment for time dependent traditional risk
factors
Model 1 Model 2 Model 3 Model 4
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI)
Baseline Risk Factors
Framingham Risk Score 2.29
(2.08, 2.53)
2.26
(2.05, 2.49)
2.25
(2.03, 2.50)
Lower SES 1.79
(1.49, 2.16)
1.53
(1.27, 1.85)
1.44
(1.19, 1.74)
Time Dependent Risk Factors
Total cholesterol (per 10 mg/dL change) 1.07 (1.03,1.10)
HDL cholesterol (per 10 mg/dL change) 1.02 (0.90,1.14)
Systolic blood pressure (per 10 mm Hg change) 1.12 (1.07,1.17)
Current Smoker 1.58 (1.05,2.39)
Anti-hypertensive medication 0.79 (0.57,1.09)
Notes: HR = adjusted hazard ratio; CI = confidence interval; SES = socio-economic status; HDL = high density lipoprotein. Framingham risk score was
complementary log log transformed: log (-log (1-Framingham risk score)). Model 1 includes SES only; Model 2 includes Framingham risk score only; Model 3
includes both SES and Framingham risk score; Model 4 adds changes in time dependent risk factors. Time dependent risk factors are changes in value of risk
factor from baseline (current-baseline). Blood pressure and lipid change scores were rescaled (by dividing by 10) to produce more interpretable hazard ratios for
these measures.
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gest that low SES during childhood predicts early coron-
ary heart disease independent of traditional risk factors
[5,27]. A growing body of evidence suggests that expo-
sure to social disadvantage and adversity in childhood
may result in lasting adaptation to stress, potentially
through epigenetic effects [28]. In addition, cumulative
effects of social disadvantage across the life course
adversely impact cardiovascular health [29]. Such
chronic stress appears to exact a physiological toll, likely
through multiple, complex pathways involving the
hypothalmic-pituitary-adrenal axis, autonomic nervous
and immune systems [30]. Thus, SES health effects may
represent a proxy measure for life-long “wear and tear.”
While these and other pathways may be important in
explaining how SES exerts its toll on CHD (and directly
addressing these pathways may be important), it remains
true that clinical decision-making based on Framingham
risk scoring alone will under-estimate CHD risk in low
SES persons.
Limitations to our findings merit comment. We did
not include other biological (such as coronary calcium
or C-reactive protein) or behavioral (such as obesity or
exercise) risk factors because none are included in Fra-
mingham risk scoring currently used in cholesterol risk
stratification and treatment guidelines. A prior analysis
showed few consistent relationships between a variety of
inflamatory markers and social mobility [5].
Participants’ reports of smoking, changes in smoking,
and anti-hypertensive medication use were not verified.
Error in assessment of these risk factors, particularly if
associated with SES bias, could result in underestimation
of the contribution of these factors. Conversely, repeated
measurement of these risk factors and the use of contin-
uous cholesterol and blood pressure measures compared
with the single baseline measurement of the dichoto-
mous SES risk factor likely results in a measurement
bias favoring the traditional risk factors. We were not
able to assess changes in SES during the study period.
For example, recent involuntary unemployment is asso-
ciated with increases in inflammation [31] and higher
cardiovascular mortality in some [32-34], but not all
[35] studies. Failing to account for these changes in SES
would result in misclassification of SES and result in a
conservative estimate of the net effect of SES on coron-
ary heart disease.
Missing follow-up data is another potential limitation.
While missing follow-up data was relatively uncommon
(6% overall), it was more common among low SES per-
sons than among high SES persons. The direction of
potential bias is difficult to estimate, depending on
whether those with missing data were less or more likely
to have changed their level of risk, and whether that
change, if any, occurred differntially by SES. However,
given the relatively small overall impact of risk factor
change on the SES hazard ratio, we consider it unlikely
that the potential bias would change our conclusion that
there is a robust independent effect of SES on CHD.
In summary, we found that accounting for changes in
key traditional coronary heart disease risk factors and
anti-hypertensive medication explained little of the inde-
pendent effect of SES on coronary heart disease risk.
Ignoring SES in coronary heart disease risk assessment
under-estimates the risk in lower SES persons [1,3], and
may, in turn, through relative undertreatment contribute
to widening SES disparities in coronary heart disease.
These findings provide further support for inclusion of
SES into coronary heart disease risk assessment; meth-
ods to do so have been presented elsewhere [22,23].
Conclusion
Using Framingham Risk Score alone under estimated
the coronary heart disease risk in low SES persons. This
bias was not eliminated by subsequent changes in Fra-
mingham risk score variables.
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